Companies in the biopharma sector developing innovative solutions and technologies.
Explore 885 recently funded biopharma companies with verified founder contact information and fundraising data.
GenSensor process Analytical Technology for in-line bioproduction monitoring.
Developer of an AI-driven bioprocess optimization platform designed to accelerate fermentation and purification development and scaleup.
Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Formulary Insights help biopharmaceutical investors, marketers, and leaders understand and anticipate payer perceptions of their product.
ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Adora Life Science is a Biotechnology firm developing and researching on pharmaceutical related to inflammation, diabetes and regeneration.
FTnet connects the Pharmaceutical Industry and Pharmacy through multi-sided technology.
Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.
Patient-centric cancer data and analytics platform for translational cancer biologists
Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.
Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
N-Zyme Biomedical develops pepsin inhibitor therapies and drug formulations for reflux diseases such as LPR and GERD.
Seed develops clinically-studied probiotics to impact human and planetary health.
Exomas develops exosome-based products that expand the cognitive reserve and induce neuronal plasticity to treat neurodegenerative diseases.
Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 885 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked